1-5 of 5
Antonio Chella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo, Federica D'Incà, Claudio Dazzi, Antonio Chella, Angelo Delmonte, Laura Bonanno, Diana Giannarelli, Diego Luigi Cortinovis, Filippo de Marinis, Gloria Borra, Alessandro Morabito, Cesare Gridelli, Domenico Galetta, Fausto Barbieri, Francesco Grossi, Enrica Capelletto, Gabriele Minuti, Francesca Mazzoni, Claudio Verusio, Emilio Bria, Greta Alì, Rossella Bruno, Agnese Proietti, Gabriella Fontanini, Lucio Crinò, Federico Cappuzzo
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (24): 7312–7319.
https://doi.org/10.1158/1078-0432.CCR-19-0994
Published: 13 December 2019
View article titled, Crizotinib in <em>MET</em>-Deregulated or <em>ROS1</em>-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial
Open the PDF for Crizotinib in <em>MET</em>-Deregulated or <em>ROS1</em>-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial in another window
Includes: Supplementary data
Journal Articles

Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer

Alfonso Cristaudo, Rudy Foddis, Agnese Vivaldi, Giovanni Guglielmi, Nicola Dipalma, Rosangela Filiberti, Monica Neri, Marcello Ceppi, Michela Paganuzzi, Gian Paolo Ivaldi, Manlio Mencoboni, Pier Aldo Canessa, Nicolino Ambrosino, Antonio Chella, Luciano Mutti, Riccardo Puntoni
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (17): 5076–5081.
https://doi.org/10.1158/1078-0432.CCR-07-0629
Published: 04 September 2007
View article titled, Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer
Open the PDF for Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer in another window
Journal Articles

Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients

Fiamma Buttitta, Carla Martella, Fabio Barassi, Lara Felicioni, Simona Salvatore, Sandra Rosini, Tommaso D'Antuono, Antonio Chella, Felice Mucilli, Rocco Sacco, Andrea Mezzetti, Franco Cuccurullo, Robert Callahan, Antonio Marchetti
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (9): 3198–3204.
https://doi.org/10.1158/1078-0432.CCR-04-2308
Published: 02 May 2005
View article titled, Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients
Open the PDF for Int6 Expression Can Predict Survival in Early-Stage Non–Small Cell Lung Cancer Patients in another window
Journal Articles

Down Regulation of High in Normal-1 ( HIN-1 ) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome

Antonio Marchetti, Fabio Barassi, Carla Martella, Antonio Chella, Simona Salvatore, Antonio Castrataro, Felice Mucilli, Rocco Sacco, Fiamma Buttitta
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (4): 1338–1343.
https://doi.org/10.1158/1078-0432.CCR-1174-03
Published: 20 February 2004
View article titled, Down Regulation of High in Normal-1 ( <em>HIN-1</em> ) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome
Open the PDF for Down Regulation of High in Normal-1 ( <em>HIN-1</em> ) is a Frequent Event in Stage I Non-Small Cell Lung Cancer and Correlates with Poor Clinical Outcome in another window
Journal Articles

Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer

Antonio Marchetti, Gloria Bertacca, Fiamma Buttitta, Antonio Chella, Gianluca Quattrocolo, Carlo Alberto Angeletti, Generoso Bevilacqua
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 2077–2081.
Published: 01 August 1999
View article titled, Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer
Open the PDF for Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer in another window